Kalliokoski, Annikka <br/><br/>
SLCO1B1 polymorphism and oral antidiabetic drugs.  [electronic resource] 

 -  Basic & clinical pharmacology & toxicology  Oct 2010 
 - 775-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1742-7843 
<br/><br/><label>Standard No.: </label>10.1111/j.1742-7843.2010.00581.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Alleles<br/>Carbamates--pharmacokinetics<br/>Cyclohexanes--pharmacokinetics<br/>Genotype<br/>Haplotypes<br/>Humans<br/>Hypoglycemic Agents--pharmacokinetics<br/>Liver-Specific Organic Anion Transporter 1<br/>Nateglinide<br/>Organic Anion Transporters--genetics<br/>Phenylalanine--analogs & derivatives<br/>Pioglitazone<br/>Piperidines--pharmacokinetics<br/>Polymorphism, Genetic<br/>Rosiglitazone<br/>Thiazolidinediones--pharmacokinetics